CSL Ltd. Registered Shares o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

59.28%

Market Cap

79.39 Bil.

P/E Ratio

25.01

Dividend Yield

1.89 %

Earnings per Share

5.71 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE56.23 G0 Units
PRICE DETERMINATION TIME06/03/2026 / 09:56:50 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW56.7656.22
PREV. DAY'S PRICE57.11 (06/02)
CHANGE DAY BEFORE
-0.88
-1.54 %
52 WEEK HIGH / LOW153.42 (07/31)56.41 (06/02)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE5.665.465.715.064.45
DIVIDENDS PER SHARE2.602.502.702.412.34
DIVIDEND YIELD IN %--1.89 %1.35 %1.31 %
DIVIDEND GROWTH IN %--11.84 %3.14 %13.97 %
PRICE - EARNINGS RATIO10.5210.9125.0135.3740.09
PRICE - BOOK RATIO--3.935.495.64
PRICE - SALES RATIO--4.896.396.85
PRICE - CASH FLOW RATIO--21.1833.9634.71
Further Key Figures

Master Data

WKN
890952
ISIN
AU000000CSL8
SYMBOL
CSJ
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
CSL
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Australian Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
483.25 Mil.
MARKET CAPITALISATION
79.39 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.86 %
-25.68 %
-36.46 %
-44.51 %
-59.28 %
-69.65 %
-68.44 %
-41.45 %
HIGH61.1877.3988.78108.78153.42192.70205.70108.78
LOW56.4156.4156.4156.4156.4156.4156.4156.41
Dividend
per share

Company profile

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.